ImportRefusal LogoImportRefusal

Upjohn Manufacturing Ireland Unlimited Company

⚠️ Moderate Risk

FEI: 3003382089 • Cork, Co. CORK • IRELAND

FEI

FEI Number

3003382089

📍

Location

Cork, Co. CORK

🇮🇪

Country

IRELAND
🏢

Address

Little Island, , Cork, Co. CORK, Ireland

Moderate Risk

FDA Import Risk Assessment

41.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

8
Total Refusals
3
Unique Violations
10/2/2014
Latest Refusal
3/13/2003
Earliest Refusal

Score Breakdown

Violation Severity
76.0×40%
Refusal Volume
35.3×30%
Recency
0.0×20%
Frequency
6.9×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

755×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

163×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

1182×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
10/2/2014
61WCY59VORICONAZOLE
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/12/2011
61JCC08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
Florida District Office (FLA-DO)
4/30/2007
61JIS99ANTI-CHOLESTEREMIC, N.E.C.
16DIRECTIONS
Seattle District Office (SEA-DO)
9/1/2006
62OCP14AMLODIPINE BESYLATE (ANTI-HYPERTENSIVE, PART II)
75UNAPPROVED
New Orleans District Office (NOL-DO)
9/1/2006
61JCP08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/8/2003
60LCB83CELECOXIB (ANALGESIC)
118NOT LISTED
75UNAPPROVED
Los Angeles District Office (LOS-DO)
3/13/2003
61JCS08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
118NOT LISTED
16DIRECTIONS
New York District Office (NYK-DO)
3/13/2003
61JCS08ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
16DIRECTIONS
New York District Office (NYK-DO)

Frequently Asked Questions

What is Upjohn Manufacturing Ireland Unlimited Company's FDA import refusal history?

Upjohn Manufacturing Ireland Unlimited Company (FEI: 3003382089) has 8 FDA import refusal record(s) in our database, spanning from 3/13/2003 to 10/2/2014.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Upjohn Manufacturing Ireland Unlimited Company's FEI number is 3003382089.

What types of violations has Upjohn Manufacturing Ireland Unlimited Company received?

Upjohn Manufacturing Ireland Unlimited Company has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Upjohn Manufacturing Ireland Unlimited Company come from?

All FDA import refusal data for Upjohn Manufacturing Ireland Unlimited Company is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.